Skip to content

Author

Thiago Oscar Goulart

We have 4 of 20 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Dec 2026

Association of Prethrombectomy Hemorrhagic Infarction on MRI With Further Transformation and Functional Outcomes: A Multicenter Study.

BACKGROUND AND OBJECTIVES Mechanical thrombectomy (MT) is the standard of care for acute ischemic stroke from large vessel occlusion (LVO). Although postprocedural parenchymal hematoma (PH) predicts poor outcomes, pretreatment hemorrhagic infarction (HI), defined as petechial bleeding within infarcted tissue, is tradit...

T. Goulart, M. Schirmer, A. Bonkhoff et al. · 0 citations
Open access Oct 2026

Pre-treatment MRI-defined brain frailty and thrombectomy outcomes: a multicenter study using STRIVE-2 criteria

Background: Mechanical thrombectomy (MT) is the standard of care for large vessel occlusion (LVO) stroke, yet nearly half of patients fail to achieve functional independence. Cerebral small vessel disease (CSVD) represents a marker of brain frailty that may impair recovery. Objective: We aimed to evaluate whether compr...

Thiago Oscar Goulart, Markus Schirmer, Yuan Ma et al. · 0 citations
Open access Oct 2026

Pre-treatment hemorrhagic infarct on MRI is associated with poor outcome after mechanical thrombectomy for stroke: a multicenter Bayesian analysis

HI detected on pre-treatment MRI is associated with worse functional outcomes and increased risk of hemorrhagic complications after thrombectomy, and may serve as a prognostic marker of reperfusion vulnerability and warrants further study as a target for neuroprotective strategies.

Thiago Oscar Goulart, M. Schirmer, Yuan Ma et al. · 0 citations
Sep 2026

STRIVE-2 MRI-Defined Brain Frailty and Functional Outcomes After Thrombectomy: A Multicenter Study.

It is suggested that while CSVD assessment improves post-thrombectomy prognostication, it should not be used as a criterion to preclude patients from MT eligibility and cumulative total CSVD burden acts as a strong, dose-dependent predictor of functional outcomes and symptomatic hemorrhage.

Thiago Oscar Goulart, Markus Schirmer, Yuan Ma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.